Comparison between Mycophenolate Mofetil and Azathioprine for Preventing Renal Relapse in Lupus Nephritis: An Evidence-based Case Report
Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease which involved many organs. One of its severe manifestations is lupus nephritis (LN). Treatment of LN consists of two phases, induction and maintenance. Inappropriate treatment approach could increase morbidity and mortality in...
Main Authors: | Bambang Setiyohadi, Muhammad Aji Muharrom |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesia Rheumatology Association
2018-12-01
|
Series: | Indonesian Journal of Rheumatology |
Online Access: | https://journalrheumatology.or.id/index.php/ijr/article/view/140 |
Similar Items
-
Mycophenolate mofetil in the treatment of lupus nephritis
by: Patrick FK Yong, et al.
Published: (2008-06-01) -
Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis
by: Robert Nee, et al.
Published: (2015-01-01) -
Off-lable uses of mycophenolate mofetil: lupus nephritis
by: B. Fernández-García, et al.
Published: (2015-07-01) -
Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01) -
Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
by: Youying Mao, et al.
Published: (2019-01-01)